Clinical impact of Prostate-Specific Membrane Antigen Positron Emission Tomography (PET) on intensification or deintensification of advanced renal cell carcinoma management.

Eur J Nucl Med Mol Imaging · 2023 · PMC10684606 · PMID 37592084

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Median time to starting systemic therapy was numerically longer for patients with negative PSMA PET in comparison to positive [36 v 21.1months p =0.28] but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.